Nauck, Michael A <br/><br/>
Individualised incretin-based treatment for type 2 diabetes.  [electronic resource] 

 -  Lancet (London, England)  Aug 2010 
 - 393-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(10)60998-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dipeptidyl-Peptidase IV Inhibitors--administration & dosage<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Exenatide<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Incretins--administration & dosage<br/>Insulin--administration & dosage<br/>Insulin Glargine<br/>Insulin, Long-Acting<br/>Metformin--administration & dosage<br/>Peptides--administration & dosage<br/>Pioglitazone<br/>Pyrazines--administration & dosage<br/>Sitagliptin Phosphate<br/>Thiazolidinediones--administration & dosage<br/>Triazoles--administration & dosage<br/>Venoms--administration & dosage